- Corporate Officers - S
- Sylvain Jereme M
Insider Trading History of Sylvain Jereme M
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Sylvain Jereme M since 2017.
This trader's CIK number is 1681267.
At the time of last reporting, Sylvain Jereme M was the EVP, Chief Financal Officer of Dexcom Inc. (stock ticker symbol DXCM).
Also see all insider trading activities at Dexcom Inc.
Note that in the past
Sylvain Jereme M also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Nuvasive Inc (NUVA) by Sylvain Jereme M
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | NUVA | 0 | $0 | 0 | $0 | 931 | $0 |
| 2017 | NUVA | 0 | $0 | 0 | $0 | 3,022 | $0 |
Yearly summary of insider trading at Dexcom Inc (DXCM) by Sylvain Jereme M
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | DXCM | 0 | $0 | 18,915 | $1,384,076 | 0 | $0 |
| 2024 | DXCM | 0 | $0 | 23,493 | $2,756,719 | 0 | $0 |
| 2023 | DXCM | 0 | $0 | 6,644 | $749,564 | 0 | $0 |
| 2022 | DXCM | 0 | $0 | 3,600 | $704,994 | 0 | $0 |
| 2021 | DXCM | 0 | $0 | 3,735 | $1,643,071 | 0 | $0 |
| 2020 | DXCM | 0 | $0 | 2,734 | $934,296 | 0 | $0 |
Insider trading activities at 2 companies by Sylvain Jereme M:
1. Nuvasive Inc (NUVA)
2. Dexcom Inc (DXCM)
Table 1. Insider trading of Nuvasive Inc (NUVA) by Sylvain Jereme M
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-02-01 | NUVA | Option Ex | 931 | .00 | 0 |
| 2017-07-01 | NUVA | Option Ex | 2,091 | .00 | 0 |
| 2017-02-01 | NUVA | Option Ex | 931 | .00 | 0 |
Table 2. Insider trading of Dexcom Inc (DXCM) by Sylvain Jereme M
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-09-02 | DXCM | Sale | 4,824 | 74.17 | 357,796 |
| 2025-03-12 | DXCM | Sale | 12,001 | 70.38 | 844,630 |
| 2025-01-29 | DXCM | Sale | 2,090 | 86.91 | 181,650 |
| 2024-12-16 | DXCM | Sale | 744 | 76.87 | 57,191 |
| 2024-11-15 | DXCM | Sale | 3,500 | 75.51 | 264,285 |
| 2024-09-09 | DXCM | Sale | 746 | 69.15 | 51,585 |
| 2024-06-10 | DXCM | Sale | 745 | 115.05 | 85,712 |
| 2024-03-12 | DXCM | Sale | 11,661 | 134.41 | 1,567,366 |
| 2024-02-20 | DXCM | Sale | 3,363 | 116.73 | 392,562 |
| 2024-01-16 | DXCM | Sale | 2,734 | 123.64 | 338,018 |
| 2023-08-22 | DXCM | Sale | 1,844 | 104.38 | 192,476 |
| 2023-05-22 | DXCM | Sale | 2,400 | 117.58 | 282,192 |
| 2023-02-22 | DXCM | Sale | 2,400 | 114.54 | 274,896 |
| 2022-11-21 | DXCM | Sale | 2,400 | 112.62 | 270,288 |
| 2022-06-06 | DXCM | Sale | 600 | 301.57 | 180,942 |
| 2022-03-04 | DXCM | Sale | 600 | 422.94 | 253,764 |
| 2021-12-06 | DXCM | Sale | 600 | 517.59 | 310,554 |
| 2021-09-09 | DXCM | Sale | 407 | 541.56 | 220,414 |
| 2021-09-07 | DXCM | Sale | 587 | 545.41 | 320,155 |
| 2021-05-24 | DXCM | Sale | 600 | 346.74 | 208,044 |
| 2021-03-10 | DXCM | Sale | 941 | 362.92 | 341,504 |
| 2021-02-24 | DXCM | Sale | 600 | 404.00 | 242,400 |
| 2020-11-24 | DXCM | Sale | 600 | 320.37 | 192,222 |
| 2020-11-10 | DXCM | Sale | 632 | 336.22 | 212,491 |
| 2020-09-09 | DXCM | Sale | 289 | 398.30 | 115,109 |
| 2020-08-24 | DXCM | Sale | 600 | 427.41 | 256,446 |
| 2020-03-11 | DXCM | Sale | 613 | 257.80 | 158,028 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Sylvain Jereme M
(EVP, Chief Financal Officer of Dexcom Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.